End-to-end CDMO | Porton Pharma Solutions

CN

A Customer-centric, Innovative
and Reliable CDMO with Global Solutions

More

Scroll

A Customer-centric, Innovative
and Reliable CDMO with Global Solutions

More

One-Stop Services & Solutions

Global Presence

Starting with small molecule drug manufacturing, Porton has expanded to a versatile range of capabilities supported by strong global professional teams and excellent facilities. Our formulation CDMO and biologics CDMO capabilities are built on the sound foundations of API crystallization, complex formulation, and gene & cell therapy technologies.

More

Environmental, Social and Corporate Governance
At Porton, we are guided by the ESG principles of “green development, promoting common progress, building a healthy society together, and enhancing corporate governance." These principles drive our sustainable development and our efforts to create greater environmental and social value.
Become part of Porton' s community to access personalized insights and resources.
Submit
By clicking “Submit” you agree to our Legal Disclaimer terms and conditions and the Porton Privacy and Cookies Policy.

ⓒ 2024 PORTON Legal Notices | Porton Privacy

This website contains information on products which are targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your countries. Please be aware that we do not take any responsibity for accessing suchinlomaon which may not compy wih anylegal process,regulaion,registraton or usage in the counry of your origin.

Become part of Porton' s community to access personalized insights and resources.
Submit
By clicking “Submit” you agree to our Legal Disclaimer terms and conditions and the Porton Privacy and Cookies Policy.

ⓒ 2024 PORTON Legal Notices | Porton Privacy

US: (609) 860-1300
CN: (86) 23-8608-3200